SCHEMBL4899437

SCHEMBL4899437

c1ccc(Nc2cccc(-c3nccs3)n2)nc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.49
MECP2 P51608 1/20 0.49
KCNN1 Q92952 1/20 0.49
KCNN2 Q9H2S1 1/20 0.49
MBD2 Q9UBB5 1/20 0.49
KCNN3 Q9UGI6 1/20 0.49
NPC1 O15118 8/20 0.48
KMT2A Q03164 8/20 0.48
TP53 P04637 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
LMNA P02545 3/20 0.48
ALOX15 P16050 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
KDM4E B2RXH2 1/20 0.48
TSHR P16473 1/20 0.48
ALOX12 P18054 1/20 0.48
HTT P42858 1/20 0.48
KLF5 Q13887 1/20 0.48
SYK P43405 5/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897056 0.84 SYK (0.47) RAB9ASYKSRCCDK2ZAP70
SCHEMBL4904404 0.83 PDPK1 (0.45) RAB9ANPC1KMT2ASYKMEN1
SCHEMBL1849187 0.82 SYK (0.62) SYKSRCCDK2ZAP70HSP90AA1
SCHEMBL4896690 0.82 SYK (0.49) RAB9ANPC1KMT2ASYKMEN1
SCHEMBL4899359 0.82 SYK (0.49) RAB9ASYKSRCCDK2ZAP70
SCHEMBL4901358 0.82 SLC2A1 (0.49) RAB9ANPC1KMT2ASMN1; SMN2LMNA
SCHEMBL27682393 0.82 RAB9A (0.40) RAB9ASYKSRCCDK2ZAP70
SCHEMBL4899942 0.82 LYN (0.49) RAB9ANPC1KMT2ATP53SMN1; SMN2
SCHEMBL4899975 0.82 RAB9A (0.40) RAB9AKMT2ALMNASYKMEN1
SCHEMBL20919346 0.82 KMT2A (0.57) RAB9AMECP2KCNN1KCNN2MBD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 RAB9A 3132/4885MECP2 2076/4885KCNN1 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.